−2.2446USD
−26.24 MUSD
About Acer Therapeutics Inc.
Acer Therapeutics is a pharmaceutical company that focuses on the acquisition, development, and commercialization of therapies for serious, rare, and life-threatening diseases with unmet medical needs. Its pipeline includes four clinical-stage candidates: emetine hydrochloride for the treatment of patients with COVID-19; ACER-001 (a taste-masked, immediate-release formulation of sodium phenylbutyrate), for the treatment of various inborn errs of metabolism, including urea cycle disorders (UCDs) and Maple Syrup Urine Disease (MSUD); EDSIVO (celiprolol), for the treatment of vascular Ehlers-Danlos syndrome (vEDS) in patients with a confirmed type III collagen (COL3A1) mutation; and osanetant, for the treatment of induced Vasomotor Symptoms (iVMS). The company was founded in 2013 and is headquartered in Newton, Massachusetts.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ACER is 0.6601 USD — it has decreased by 17.95% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Acer Therapeutics Inc. stocks are traded under the ticker ACER.
Acer Therapeutics Inc. is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
ACER stock is 28.77% volatile and has beta coefficient of 2.08. Check out the list of the most volatile stocks — is Acer Therapeutics Inc. there?
ACER earnings for the last quarter are −0.33 USD per share, whereas the estimation was −0.25 USD resulting in a −32.00% surprise. The estimated earnings for the next quarter are −0.13 USD per share. See more details about Acer Therapeutics Inc. earnings.
Acer Therapeutics Inc. revenue for the last quarter amounts to 360.00 K USD despite the estimated figure of 3.33 M USD. In the next quarter revenue is expected to reach 2.50 M USD.
Yes, you can track Acer Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
ACER net income for the last quarter is −14.73 M USD, while the quarter before that showed −8.09 M USD of net income which accounts for −82.08% change. Track more Acer Therapeutics Inc. financial stats to get the full picture.
No, ACER doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ACER shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Acer Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 33.00 employees. See our rating of the largest employees — is Acer Therapeutics Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Acer Therapeutics Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Acer Therapeutics Inc. stock shows the sell signal. See more of Acer Therapeutics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.